Status:
COMPLETED
Rollover Protocol for Prior SU011248 Protocols
Lead Sponsor:
Pfizer
Conditions:
Solid Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol
Eligibility Criteria
Inclusion
- Prior SU011248 Protocol.
- Eligible to continue SU011248 treatment.
Exclusion
- Uncontrolled CNS metastasis.
- Unfit to receive SU011248.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT00798889
Start Date
March 1 2004
End Date
December 1 2011
Last Update
January 21 2013
Active Locations (59)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Birmingham, Alabama, United States, 35233-2115
2
Pfizer Investigational Site
Birmingham, Alabama, United States, 35233
3
Pfizer Investigational Site
Birmingham, Alabama, United States, 35294
4
Pfizer Investigational Site
Los Angeles, California, United States, 90033